Report cover image

Aquaculture Therapeutics Market by Product (Chorionic Gonadotropin, Florfenicol, Formalin Solution), Distribution Channel (eCommerce, Veterinary Pharmacies) - Global Forecast 2024-2030

Publisher 360iResearch
Published Jan 15, 2024
Length 180 Pages
SKU # IRE18418477

Description

Aquaculture Therapeutics Market by Product (Chorionic Gonadotropin, Florfenicol, Formalin Solution), Distribution Channel (eCommerce, Veterinary Pharmacies) - Global Forecast 2024-2030


The Aquaculture Therapeutics Market size was estimated at USD 2.51 billion in 2023 and expected to reach USD 2.74 billion in 2024, at a CAGR 9.13% to reach USD 4.64 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Aquaculture Therapeutics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Aquaculture Therapeutics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Aquaculture Therapeutics Market, highlighting leading vendors and their innovative profiles. These include ACD Pharma, AgriSea, Aqua Pharma Group, AquaBounty Technologies, Inc., Aquaculture of Texas Inc, Aquafarm Equipment AS, Benchmark Holdings PLC, Biofeyn, Bionor Laboratories, Blue Ocean Mariculture, Ceva Santé Animale, Elanco Animal Health Incorporated, Innovasea Systems Inc., Kennebec River Biosciences, Merck & Co., Inc., Nutreco NV, OCEANIUM, Proteon Pharmaceuticals S.A., Syndel Laboratories, TeOra Pte. Ltd., TunaTech GmbH, Unibio Group, ViAqua Therapeutics, VXL DRUGS PRIVATE LIMITED, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Aquaculture Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product

Chorionic Gonadotropin
  • Florfenicol
  • Formalin Solution
  • Hydrogen Peroxide
  • Oxytetracycline
  • Tricaine Methane Sulfonate
  • Distribution Channel

    eCommerce
  • Veterinary Pharmacies
  • Region

    Americas

    Argentina
  • Brazil
  • Canada
  • Mexico
  • United States

    California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas
  • Asia-Pacific

    Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam
  • Europe, Middle East & Africa

    Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom
    The report offers valuable insights on the following aspects:

    1. Market Penetration: It presents comprehensive information on the market provided by key players.
    2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
    3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
    4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
    5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
    The report addresses key questions such as:

    1. What is the market size and forecast of the Aquaculture Therapeutics Market?
    2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Aquaculture Therapeutics Market?
    3. What are the technology trends and regulatory frameworks in the Aquaculture Therapeutics Market?
    4. What is the market share of the leading vendors in the Aquaculture Therapeutics Market?
    5. Which modes and strategic moves are suitable for entering the Aquaculture Therapeutics Market?


    Note: PDF & Excel + Online Access - 1 Year

    • Table of Contents

    180 Pages
    1. Preface
    1.1. Objectives of the Study
    1.2. Market Segmentation & Coverage
    1.3. Years Considered for the Study
    1.4. Currency & Pricing
    1.5. Language
    1.6. Limitations
    1.7. Assumptions
    1.8. Stakeholders
    2. Research Methodology
    2.1. Define: Research Objective
    2.2. Determine: Research Design
    2.3. Prepare: Research Instrument
    2.4. Collect: Data Source
    2.5. Analyze: Data Interpretation
    2.6. Formulate: Data Verification
    2.7. Publish: Research Report
    2.8. Repeat: Report Update
    3. Executive Summary
    4. Market Overview
    4.1. Introduction
    4.2. Aquaculture Therapeutics Market, by Region
    5. Market Insights
    5.1. Market Dynamics
    5.1.1. Drivers
    5.1.1.1. Growing aquaculture industry worldwide
    5.1.1.2. Rising bacterial disease affecting the animals cultured in the aquaculture
    5.1.1.3. Favourable government approvals for aquaculture drugs
    5.1.2. Restraints
    5.1.2.1. Occurrence of resistance to antimicrobial agents in aquaculture therapeutics
    5.1.3. Opportunities
    5.1.3.1. Advances in aquaculture therapeutics and growing demand for the more effective aquaculture therapeutic drugs
    5.1.3.2. Extensive government initiatives to support R&D in aquaculture therapeutics
    5.1.4. Challenges
    5.1.4.1. Side effects of consuming aquaculture drugs
    5.2. Market Segmentation Analysis
    5.3. Market Trend Analysis
    5.4. Cumulative Impact of High Inflation
    5.5. Porter’s Five Forces Analysis
    5.5.1. Threat of New Entrants
    5.5.2. Threat of Substitutes
    5.5.3. Bargaining Power of Customers
    5.5.4. Bargaining Power of Suppliers
    5.5.5. Industry Rivalry
    5.6. Value Chain & Critical Path Analysis
    5.7. Regulatory Framework
    6. Aquaculture Therapeutics Market, by Product
    6.1. Introduction
    6.2. Chorionic Gonadotropin
    6.3. Florfenicol
    6.4. Formalin Solution
    6.5. Hydrogen Peroxide
    6.6. Oxytetracycline
    6.7. Tricaine Methane Sulfonate
    7. Aquaculture Therapeutics Market, by Distribution Channel
    7.1. Introduction
    7.2. eCommerce
    7.3. Veterinary Pharmacies
    8. Americas Aquaculture Therapeutics Market
    8.1. Introduction
    8.2. Argentina
    8.3. Brazil
    8.4. Canada
    8.5. Mexico
    8.6. United States
    9. Asia-Pacific Aquaculture Therapeutics Market
    9.1. Introduction
    9.2. Australia
    9.3. China
    9.4. India
    9.5. Indonesia
    9.6. Japan
    9.7. Malaysia
    9.8. Philippines
    9.9. Singapore
    9.10. South Korea
    9.11. Taiwan
    9.12. Thailand
    9.13. Vietnam
    10. Europe, Middle East & Africa Aquaculture Therapeutics Market
    10.1. Introduction
    10.2. Denmark
    10.3. Egypt
    10.4. Finland
    10.5. France
    10.6. Germany
    10.7. Israel
    10.8. Italy
    10.9. Netherlands
    10.10. Nigeria
    10.11. Norway
    10.12. Poland
    10.13. Qatar
    10.14. Russia
    10.15. Saudi Arabia
    10.16. South Africa
    10.17. Spain
    10.18. Sweden
    10.19. Switzerland
    10.20. Turkey
    10.21. United Arab Emirates
    10.22. United Kingdom
    11. Competitive Landscape
    11.1. FPNV Positioning Matrix
    11.2. Market Share Analysis, By Key Player
    11.3. Competitive Scenario Analysis, By Key Player
    12. Competitive Portfolio
    12.1. Key Company Profiles
    12.1.1. ACD Pharma
    12.1.2. AgriSea
    12.1.3. Aqua Pharma Group
    12.1.4. AquaBounty Technologies, Inc.
    12.1.5. Aquaculture of Texas Inc
    12.1.6. Aquafarm Equipment AS
    12.1.7. Benchmark Holdings PLC
    12.1.8. Biofeyn
    12.1.9. Bionor Laboratories
    12.1.10. Blue Ocean Mariculture
    12.1.11. Ceva Santé Animale
    12.1.12. Elanco Animal Health Incorporated
    12.1.13. Innovasea Systems Inc.
    12.1.14. Kennebec River Biosciences
    12.1.15. Merck & Co., Inc.
    12.1.16. Nutreco NV
    12.1.17. OCEANIUM
    12.1.18. Proteon Pharmaceuticals S.A.
    12.1.19. Syndel Laboratories
    12.1.20. TeOra Pte. Ltd.
    12.1.21. TunaTech GmbH
    12.1.22. Unibio Group
    12.1.23. ViAqua Therapeutics
    12.1.24. VXL DRUGS PRIVATE LIMITED
    12.1.25. Zoetis Inc.
    12.2. Key Product Portfolio
    13. Appendix
    13.1. Discussion Guide
    13.2. License & Pricing
    FIGURE 1. AQUACULTURE THERAPEUTICS MARKET RESEARCH PROCESS
    FIGURE 2. AQUACULTURE THERAPEUTICS MARKET SIZE, 2023 VS 2030
    FIGURE 3. AQUACULTURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
    FIGURE 4. AQUACULTURE THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
    FIGURE 5. AQUACULTURE THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 6. AQUACULTURE THERAPEUTICS MARKET DYNAMICS
    FIGURE 7. AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
    FIGURE 8. AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 9. AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
    FIGURE 10. AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 11. AMERICAS AQUACULTURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 12. AMERICAS AQUACULTURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 13. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
    FIGURE 14. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 15. ASIA-PACIFIC AQUACULTURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 16. ASIA-PACIFIC AQUACULTURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 17. EUROPE, MIDDLE EAST & AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 18. EUROPE, MIDDLE EAST & AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 19. AQUACULTURE THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
    FIGURE 20. AQUACULTURE THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023

    Pricing

    Currency Rates
    How Do Licenses Work?

    How Do Licenses Work?

    The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

    • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

    • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

    • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

    • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

    • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

    License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

    Head shot

    Questions or Comments?

    Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
    Chat Now
    Contact Us